Conference
Benralizumab attenuates blood and airway eosinophilia in severe asthmatics with inadequate response to anti-IL-5 neutralizing antibodies
Authors
Mukherjee M; Bhalla A; Venegas-Garrido C; Huang C; Radford K; Kjarsgaard M; Lauks S; Son K; Lavigne N; Sehmi R
Publisher
European Respiratory Society (ERS)
Publication Date
September 4, 2022
DOI
10.1183/13993003.congress-2022.3994
Name of conference
05.01 - Airway pharmacology and treatment